Percutaneous administration

阅读量:

10

申请(专利)号:

JP2020005375

申请日期:

20200116

公开/公告号:

JP2020143042A

公开/公告日期:

20200910

申请(专利权)人:

日本臓器製薬株式会社

发明人:

増田 敦安達 毅佐々木 一高

展开

国省代号:

JP

摘要:

Problem to be solved: to provide a fentanyl containing transdermal administration agent capable of reducing the decrease in analgesic effect occurring on the third day after pasting. The present invention comprises a support, a drug containing layer stacked on the support, a drug control membrane which is laminated on the drug containing layer and is permeable through the drug, and an adhesive layer stacked on the drug control film The drug containing layer comprises an adhesive and a drug containing particle comprising fentanyl or its pharmaceutically acceptable salt and dissolving agent dispersed in the adhesive When the percutaneous administration was affixed to the skin for 72 hours, the concentration of fentanyl or its pharmaceutically acceptable salt during the period of 48 to 72 hours was greater than 0.2 ng / ml or more than A transdermal administration agent with an adjustable coefficient of acc48-72 of less than 35% is available. Diagram

展开

通过文献互助平台发起求助,成功后即可免费获取论文全文。

相似文献

参考文献

引证文献

辅助模式

0

引用

文献可以批量引用啦~
欢迎点我试用!

引用